In addition, angiogenesis is a prominent feature of aggressive malignancies (21), including brain tumors, and the level of circulating VEGF is positively associated with tumor aggressiveness, making VEGF a promising therapeutic target for high-grade malignant brain tumors (52, 53). Here, VEGFA is linked to neoplasm.